Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Blood pressure influences end-stage renal disease of Cd151 knockout mice
Norman Sachs, … , Hans Janssen, Arnoud Sonnenberg
Norman Sachs, … , Hans Janssen, Arnoud Sonnenberg
Published December 27, 2011
Citation Information: J Clin Invest. 2012;122(1):348-358. https://doi.org/10.1172/JCI58878.
View: Text | PDF | Corrigendum
Research Article

Blood pressure influences end-stage renal disease of Cd151 knockout mice

  • Text
  • PDF
Abstract

Podocytes of the kidney adhere tightly to the underlying glomerular basement membrane (GBM) in order to maintain a functional filtration barrier. The clinical importance of podocyte binding to the GBM via an integrin-laminin-actin axis has been illustrated in models with altered function of α3β1 integrin, integrin-linked kinase, laminin-521, and α-actinin 4. Here we expanded on the podocyte-GBM binding model by showing that the main podocyte adhesion receptor, integrin α3β1, interacts with the tetraspanin CD151 in situ in humans. Deletion of Cd151 in mouse glomerular epithelial cells led to reduced adhesive strength to laminin by redistributing α3β1 at the cell-matrix interface. Moreover, in vivo podocyte-specific deletion of Cd151 led to glomerular nephropathy. Although global Cd151-null B6 mice were not susceptible to renal disease, as has been shown previously, increasing blood and transcapillary filtration pressure induced nephropathy in these mice. Importantly, blocking the angiotensin-converting enzyme in renal disease–susceptible global Cd151-null FVB mice prolonged their median life span. Together, these results establish CD151 as a crucial modifier of integrin-mediated adhesion of podocytes to the GBM and show that blood pressure is an important factor in the initiation and progression of Cd151 knockout–induced nephropathy.

Authors

Norman Sachs, Nike Claessen, Jan Aten, Maaike Kreft, Gwendoline J.D. Teske, Anneke Koeman, Coert J. Zuurbier, Hans Janssen, Arnoud Sonnenberg

×

Figure 3

Generation and characterization of GECs with or without Cd151.

Options: View larger image (or click on image) Download as PowerPoint
Generation and characterization of GECs with or without Cd151.
   
(A) G...
(A) GECs isolated from an adult Cd151fl/fl;Trp53+/– mouse. (B) Cell surface expression of Cd151 was absent after Cre-mediated recombination in vitro, as shown by FACS. GEC+, Cd151-positive GECs; GEC-, Cd151-negative GECs. (C) Immunofluorescent analysis of confluent Cd151-positive and -negative GEC monolayers showing similar cell size as well as comparable actin, nephrin, podocin, and cadherin distribution. (D) Western blot analysis of whole cell lysates (WCL) showing absence of Cd151 in the Cd151-negative GECs and CD151 being coimmunoprecipitated with α3 in Cd151-positive, but not Cd151-negative, GECs. (E) Western blot analysis of immunoprecipitations of α3 and FLAG-tagged human CD151 rescue constructs. CD151 coimmunoprecipitated with α3 only when the QRD integrin-binding motif was intact. GEC-reWT, Cd151-negative GECs rescued with human wild-type CD151; GEC-reQRD*, Cd151-negative GECs rescued with the mutated 194QRD–INF196 sequence of human CD151. Scale bars: 100 μm (A, top, and C, triple stain), 25 μm (A, bottom, and C, single stains).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts